Jc Biotech Profile
Key Indicators
- Authorised Capital ₹ 21.00 Cr
as on 29-07-2024
- Paid Up Capital ₹ 20.71 Cr
as on 29-07-2024
- Company Age 32 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.00 Cr
as on 29-07-2024
- Satisfied Charges ₹ 67.29 Cr
as on 29-07-2024
- Revenue -0.33%
(FY 2023)
- Profit -125.16%
(FY 2023)
- Ebitda -89.97%
(FY 2023)
- Net Worth -3.10%
(FY 2023)
- Total Assets 4.05%
(FY 2023)
About Jc Biotech
The Corporate was formerly known as Chaganti Finances & Investments Pvt Ltd. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 21.00 Cr and a paid-up capital of Rs 20.71 Cr.
The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹67.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jc Biotech Private Limited India are Siva Tssn as CFO and Pranit Dalvi as Company Secretary. Mukund Kabra, Beni Rauka, Kedar Desai, and Three other members serve as directors at the Company.
- CIN/LLPIN
U65993TG1991PTC013624
- Company No.
013624
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 1991
- Date of AGM
25 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jc Biotech Private Limited offer?
Jc Biotech Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Flavours & Aromatics, Food Enzymes.
Who are the key members and board of directors at Jc Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siva Tssn | CFO | 30-Jan-2019 | Current |
| Pranit Dalvi | Company Secretary | 22-Mar-2022 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Kasat  | Director | 13-Feb-2017 | Current |
| Mukund Kabra | Director | 01-Dec-2016 | Current |
| Beni Rauka | Director | 30-Jan-2019 | Current |
| Kedar Desai | Director | 13-Feb-2017 | Current |
| Naveenkrishna Bondalapati | Whole-Time Director | 02-Apr-2015 | Current |
| Satish Pagar | Director | 30-Jan-2019 | Current |
Financial Performance and Corporate Structure Insights of Jc Biotech.
Jc Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.33% decrease. The company also saw a substantial fall in profitability, with a 125.16% decrease in profit. The company's net worth dipped by a decrease of 3.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jc Biotech?
In 2023, Jc Biotech had a promoter holding of 97.55% and a public holding of 2.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Advanced Enzytech Solutions LimitedActive 16 years 3 monthsMukund Kabra and Beni Rauka are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 13 Aug 2020 | ₹10.00 Cr | Open |
Yes Bank Limited Creation Date: 29 May 2017 | ₹9.80 Cr | Satisfied |
Yes Bank Limited Creation Date: 12 Apr 2017 | ₹9.80 Cr | Satisfied |
How Many Employees Work at Jc Biotech?
Unlock and access historical data on people associated with Jc Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jc Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jc Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
